Cancer immunotherapy isn’t just treatment – it’s a breakthrough
Parker Institute for Cancer Immunotherapy shared a post on LinkedIn by The Nobel Prize adding:
“Cancer immunotherapy isn’t just treatment – it’s a breakthrough.
Hear from James P. Allison, PhD, Director of the PICI Center at MD Anderson Cancer Center, and Tasuku Honjo, MD, PhD, Director of the Center for Cancer Immunotherapy and Immunobiology at Kyoto University, recipients of 2018 Nobel Prize in Physiology or Medicine, on how their discoveries in CTLA-4 and PD-1 transformed the fight against cancer, offering patients a path to lasting remission.
Quoting The Nobel Prize’s post below:
“‘This isn’t just a cancer therapy. This is a way of liberating people from the burden of having a disease that could come back and kill you.’
On World Cancer Day, medicine laureates James Allison and Tasuku Honjo share their personal experiences with cancer and the hope their remarkable cancer treatment – immunotherapy – gives to patients around the globe.”
Watch the video attached to the post.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023